CRFR

R121919 is a potent small-molecule CRF1 receptor antagonist.

Verucerfont, also known as GSK561679 and NBI77860, is a CRF-1 antagonist. Verucerfont blocks the CRH-1 receptor, and so reduces ACTH release following chronic stress.